Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
It is actually a new ISO Class 5 controlled cleanroom designed to deliver washed, dried, and gamma-sterilized single-use assemblies ready for immediate use.
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Targets high-growth eye care expansion push
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
The programme integrates simulation-based training, expert-led sessions, and case-based discussions
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
The cleanroom operates under stringent ISO Class 5 conditions, using ultrapure water and air systems
Subscribe To Our Newsletter & Stay Updated